Rasagiline - Second-Generation MAO-B Inhibitor for the Treatment of Parkinson's Disease


Cross-section of the human brain showing the substantia nigra, the region affected by Parkinson's disease. (Source: ABPI)

  • Cross-section of the human brain
  • Some examples of new approaches to the treatment of PD
  • Drugs currently used in the treatment of PD
  • Drugs currently used in the treatment of PD
  • Common symptoms associated with PD


| 1 | 2 | 3 | 4 | 5 |

Browse More Images - Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development